Opening book details…
Can I read Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission on EtoBox?
Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission by Takashi Kumagai; Chiaki Nakaseko; Kaichi Nishiwaki; Chikashi Yoshida; Kazuteru Ohashi; Naoki Takezako; Hina Takano; Yasuji Kouzai; Tadashi Murase; Kosei Matsue; Satoshi Morita; Junichi Sakamoto; Hisashi Wakita; Hisashi Sakamaki; Koiti Inokuchi; the Kanto CML, Shimousa Hematology Study Groups is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
What is Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission about?
## Abstract This study presents the final report of the multicenter, prospective tyrosine kinase inhibitor discontinuation study, D‐STOP, after a 3‐year follow‐up of 54 patients with chronic CML who discontinued dasatinib after a sustained deep molecular response (DMR) for ≥2 years with dasatinib treatment. Estimated treatment‐free remission (TFR) rates at 12 and 36 months were 63.0% [95% confidence interval (CI): 48.7‐74.3] and 59.3% (95% CI: 45.0‐71.0), respectively. CD3^−^CD56^+^ NK, CD16^+^CD56^+^ NK, and CD57^+^CD56^+^ NK large granular lymphocyte (NK‐LGL), CD8^+^CD4^–^ cytotoxic T cell, and CD57^+^CD3^+^ T‐LGL cell numbers were relatively elevated throughout the 24‐month consolidation only in failed patients who molecularly relapsed within 12 months. In successful patients, these subsets elevated transiently after 12 months, but returned to basal levels after 24‐month consolidation. Therefore, smaller changes in NK/T, particularly the NK subset throughout consolidation, reflected higher TFR rates. TFR rates of those patients exhibiting elevation in CD3^−^CD56^+^ NK >376 cells/μL, CD16^+^CD56^+^ NK > 241 cells/μL, or CD57^+^CD56^+^ NK‐LGL >242 cells/μL during consolidation com
Who reads Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission?
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Takashi Kumagai; Chiaki Nakaseko; Kaichi Nishiwaki; Chikashi Yoshida; Kazuteru Ohashi; Naoki Takezako; Hina Takano; Yasuji Kouzai; Tadashi Murase; Kosei Matsue; Satoshi Morita; Junichi Sakamoto; Hisashi Wakita; Hisashi Sakamaki; Koiti Inokuchi; the Kanto CML, Shimousa Hematology Study Groups
- Publisher
- Wiley
- Published
- 2020
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)